Join ERDERA’s extended webinar on the Joint Transnational Call on 14 January

Following the success of our previous session, ERDERA warmly invites researchers, patient advocates, and early-career professionals to an extended webinar on 14 January 2025. This webinar is part of the 2025 Joint Transnational Call for Proposals, “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation”, which was officially launched on 10 December 2024.

Click here to register for the webinar. 

This Webinar will: 

  • Inform applicants about lessons learned about the evaluation.
  • Guide applicants with key translational, regulatory, data managing, and methodological considerations for drafting strong pre-proposals.
  • Address your questions through dedicated Q&A sessions.

Agenda (CET) 

  • 14.00-14.10 Introduction (Ralph Schuster)
  • 14.10-14.20 Lessons learned from previous calls – evaluators perspective  
    (Christine Kinnon)
  • 14.20-14.30 Q&A Round 1
  • 14.30-14.45 Innovating Management Toolbox (IMT) and Mentoring service (Agustin Arasanz Duque, Rosan Kreeftmeijer-Vegter, Toni Andreu)
  • 14.45-15.00 Regulatory Support Service (Viviana Giannuzzi, David Morrow)
  • 15.00-15.10 Q&A Round 2
  • 15.10-15.25 Methodological Support (Rima Nabbout)
  • 15.25-15.40 Data standards and FAIRification (Marco Roos)
  • 15.40-15.50 Q&A Round 3
  • 15.50-16.00 Closing remarks   

Registration is mandatory 

  • The registration deadline is 14 January 2025.  
  • Upon submitting your registration, you will receive connection links and calendar invitations to ensure seamless participation.  

 Note: The webinar will be recorded, and the video recording will be made available exclusively to registered participants. 

Don’t miss this chance to get ahead in the application process and ensure that your project stands out! 

Find out more details about ERDERA’s Joint Transnational Call 2025 – Announcement here. 

News & Updates

You might also be interested in

Woman helping out a person with a disease

Women’s Day highlights widening gender inequalities in rare diseases

Drawing on Europe-wide patient and carer surveys, ERDERA highlights how gender can shape diagnostic delays, care burden and the evidence base for rare-disease research.
European Parliament Photograph

New European Parliament study maps options for an EU rare disease action plan

European Parliament research service assessment, published in February 2026, identifies 31 measures that could form an EU rare disease action plan, highlighting European Reference Networks and cross-border collaboration including ERDERA as drivers of EU added value.
Publicaciones (1)

EU rare disease action plan- European Added Value Assessment

This study investigates possible measures that could be taken at EU level to address these challenges. It finds significant European added value in harmonising coordination and access across the 27 Member States, mainly in terms of improved diagnostic tools and availability of medical treatment, better health outcomes, particularly lower infant mortality, and improved well-being of family members and caregivers.
Rare Disease Day 2026 visual representation

One year of ERDERA: the European alliance built to accelerate rare disease research reports first results

28 February, across Europe and beyond: one year into delivery, ERDERA is advancing towards shorten diagnostic journeys and improved therapies for people living with a rare disease.

ERDERA's

search form